A research team led by the Department of Medicine, under the School of Clinical Medicine, LKS Faculty of Medicine of the ...
A research team led by the Department of Medicine, under the School of Clinical Medicine, LKS Faculty of Medicine of the University of Hong Kong (HKUMed), has synergised impacts of worldwide clinical ...
A phase II trial of dostarlimab and niraparib combination therapy in patients with stage III-IV recurrent or refractory penile cancer. Association of baseline and on-treatment ctDNA fraction with ...
Vericiguat is a candidate for inclusion in guideline-directed medical therapy for heart failure with reduced ejection fraction, based on a meta-analysis showing an all-cause death reduction on top of ...